Randomized, Double-Blind, Placebo-Controlled Trial of Ferric Carboxymaltose Versus Placebo in Patients with Congestive Heart Failure

Trial Profile

Randomized, Double-Blind, Placebo-Controlled Trial of Ferric Carboxymaltose Versus Placebo in Patients with Congestive Heart Failure

Discontinued
Phase of Trial: Phase III

Latest Information Update: 20 May 2016

At a glance

  • Drugs Ferric carboxymaltose (Primary)
  • Indications Heart failure; Iron deficiency anaemia
  • Focus Therapeutic Use
  • Acronyms iCHF
  • Most Recent Events

    • 26 Jun 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
    • 07 Feb 2015 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 03 Jul 2014 Planned primary completion date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top